<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38586062</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2772-3682</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The Lancet regional health. Southeast Asia</Title><ISOAbbreviation>Lancet Reg Health Southeast Asia</ISOAbbreviation></Journal><ArticleTitle>Prevalence of long COVID symptoms in Haryana, India: a cross-sectional follow-up study.</ArticleTitle><Pagination><StartPage>100395</StartPage><MedlinePgn>100395</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100395</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.lansea.2024.100395</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Emerging research indicates growing concern over long COVID globally, although there have been limited studies that estimate population burden. We aimed to estimate the burden of long COVID in three districts of Haryana, India, using an opportunity to link a seroprevalence study to follow-up survey of symptoms associated with long COVID.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We used a population-based seroprevalence survey for COVID-19 conducted in September 2021 across Haryana, India. Adults from three purposively selected districts (Rohtak, Gurugram, and Jhajjar) were eligible to participate; 2205 of 3213 consented to participate in a survey on health status. Trained investigators administered a structured questionnaire that included demographic characteristics, self-reported symptoms of illness in the last six months before the survey, mental health, and history of COVID-19.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">Unadjusted regression estimates indicated positive correlations between symptomatic complaints and COVID-19 exposure, suggesting lingering effects of COVID-19 in this population. The overall physical morbidity index was higher among those who tested positive for COVID-19, as was the incidence of new cases. However, both morbidity and incidence became statistically insignificant after adjustment for multiple comparisons. Cough emerged as the only statistically significant individual persistent symptom. Sex-stratified analyses indicated significant estimates only for physical morbidity in women.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">This study is one of the first from India that uses a large population-based sample to examine longer term repercussions of COVID infections. The burden of long COVID should primarily be addressed in clinical settings, where specialised treatment for individual cases continues to evolve. Our analyses also provide insight into the size and nature of studies required to assess the population-level burden of long COVID.</AbstractText><AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">This paper was produced under the auspices of the Lancet COVID 19 Commission India Task Force, which was supported financially by the Reliance Foundation. The Lancet COVID 19 Commission was set up in July 2020 and submitted its final report by October 2022. This report by the India Task Force was prepared during the same period.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chaudhry</LastName><ForeName>Dhruva</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Dept of Pulmonary &amp; Critical Care Medicine, Pt BDS Post Graduate Institute of Medical Sciences (PGIMS), Rohtak, Haryana, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khandelwal</LastName><ForeName>Shweta</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Public Health Foundation of India, Gurugram, Haryana, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahadur</LastName><ForeName>Chandrika</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Sustainable Development Solutions Network, Delhi and New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daniels</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Georgetown University, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhattacharyya</LastName><ForeName>Malay</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Indian Statistical Institute, Kolkata, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gangakhedkar</LastName><ForeName>Raman</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Indian Council of Medical Research (ICMR), Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desai</LastName><ForeName>Sapna</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Population Council Institute, Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Das</LastName><ForeName>Jishnu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Georgetown University, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Long COVID India study group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Reg Health Southeast Asia</MedlineTA><NlmUniqueID>9918419282806676</NlmUniqueID><ISSNLinking>2772-3682</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Community survey</Keyword><Keyword MajorTopicYN="N">Haryana</Keyword><Keyword MajorTopicYN="N">India</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Seroprevalence</Keyword></KeywordList><CoiStatement>All the authors have declared no conflict of interest.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Gupta</LastName><ForeName>Usha</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singh</LastName><ForeName>Veena</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garg</LastName><ForeName>Shalu</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bhardwaj</LastName><ForeName>Liza</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chayal</LastName><ForeName>Vinod</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arora</LastName><ForeName>Varun</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singh</LastName><ForeName>Pawan Kumar</ForeName><Initials>PK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khan</LastName><ForeName>Nizamuddin</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garg</LastName><ForeName>Suneela</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Godbole</LastName><ForeName>Sheela</ForeName><Initials>S</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>8</Day><Hour>4</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38586062</ArticleId><ArticleId IdType="pmc">PMC10998228</ArticleId><ArticleId IdType="doi">10.1016/j.lansea.2024.100395</ArticleId><ArticleId IdType="pii">S2772-3682(24)00045-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Mahoney L.L., Routen A., Gillies C., et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine. 2023;55 doi: 10.1016/j.eclinm.2022.101762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE  . 2021. Overview COVID-19 rapid guideline: managing the long-term effects of COVID-19 guidance NICE, the scottish intercollegiate guidelines network (SIGN) and the royal college of general practitioners (RCGP)https://www.nice.org.uk/guidance/NG188</Citation></Reference><Reference><Citation>WHO  . WHO; 2022. Post COVID-19 condition (long COVID)https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition</Citation></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1) doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson S.W., Abbafati C., Aerts J.G., et al. A&#xa0;global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021. medRxiv. 2022 doi: 10.1101/2022.05.26.22275532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.26.22275532</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J.D., Pellicer-Valero &#xd3;.J., et al. Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms: the LONG-COVID-EXP-CM multicenter study. J&#xa0;Clin Med. 2022;11(2):413. doi: 10.3390/jcm11020413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Rees E.M., Nightingale E.S., Jafari Y., et al. COVID-19 length of hospital stay: a systematic review and data synthesis. BMC Med. 2020;18(1):270. doi: 10.1186/s12916-020-01726-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01726-3</ArticleId><ArticleId IdType="pmc">PMC7467845</ArticleId><ArticleId IdType="pubmed">32878619</ArticleId></ArticleIdList></Reference><Reference><Citation>Afroze F., Arafat S.M., Ahmed C.M., et al. Features and risk factors of post-COVID-19 syndrome: findings from a longitudinal study in Bangladesh. Lancet Reg Health Southeast Asia. 2023;11 doi: 10.1016/j.lansea.2022.100134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lansea.2022.100134</ArticleId><ArticleId IdType="pmc">PMC9780633</ArticleId><ArticleId IdType="pubmed">36575774</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur U., Bala S., Joshi A., et al. Persistent health issues, adverse events, and effectiveness of vaccines during the second wave of COVID-19: a cohort study from a tertiary hospital in north India. Vaccines (Basel) 2022;10(7):1153. doi: 10.3390/vaccines10071153.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10071153</ArticleId><ArticleId IdType="pmc">PMC9319407</ArticleId><ArticleId IdType="pubmed">35891317</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., Geddes J.R., Husain M., Harrison P.J. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9) doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Spanos M., Shachar S., Sweeney T., et al. Elevation of neural injury markers in patients with neurologic sequelae after hospitalization for SARS-CoV-2 infection. iScience. 2022;25(8) doi: 10.1016/j.isci.2022.104833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.104833</ArticleId><ArticleId IdType="pmc">PMC9341164</ArticleId><ArticleId IdType="pubmed">35937088</ArticleId></ArticleIdList></Reference><Reference><Citation>Anjana N.K.N., Annie T.T., Siba S., Meenu M.S., Chintha S., Anish T.S.N. Manifestations and risk factors of post COVID syndrome among COVID-19 patients presented with minimal symptoms - a study from Kerala, India. J&#xa0;Family Med Prim Care. 2021;10(11):4023&#x2013;4029. doi: 10.4103/jfmpc.jfmpc_851_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_851_21</ArticleId><ArticleId IdType="pmc">PMC8797119</ArticleId><ArticleId IdType="pubmed">35136762</ArticleId></ArticleIdList></Reference><Reference><Citation>Areekal B., Sukumaran S.T., Andrews A.M., et al. Persistence of symptoms after acute COVID-19 infection- an experience from a tertiary care centre in south India. J&#xa0;Clin Diagn Res. 2021;16(6):LC05&#x2013;LC08. doi: 10.7860/JCDR/2021/49600.14967.</Citation><ArticleIdList><ArticleId IdType="doi">10.7860/JCDR/2021/49600.14967</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra N., Chowdhury M., Singh A.K., et al. Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India. Drug Discov Ther. 2021;15(3):156&#x2013;161. doi: 10.5582/ddt.2021.01014.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/ddt.2021.01014</ArticleId><ArticleId IdType="pubmed">34234065</ArticleId></ArticleIdList></Reference><Reference><Citation>Naik S., Haldar S.N., Soneja M., et al. Post COVID-19 sequelae: a prospective observational study from Northern India. Drug Discov Ther. 2021;15(5):254&#x2013;260. doi: 10.5582/ddt.2021.01093.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/ddt.2021.01093</ArticleId><ArticleId IdType="pubmed">34719599</ArticleId></ArticleIdList></Reference><Reference><Citation>P S., Madhavan S., Pandurangan V. Prevalence, pattern and functional outcome of post COVID-19 syndrome in older adults. Cureus. 2021;13(8) doi: 10.7759/cureus.17189.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.17189</ArticleId><ArticleId IdType="pmc">PMC8369971</ArticleId><ArticleId IdType="pubmed">34422503</ArticleId></ArticleIdList></Reference><Reference><Citation>Bank W., Aayog N., Welfare MoHaF  . 2021. Healthy States, Progressive India: HEALTH INDEX ROUND IV 2019-20.https://www.niti.gov.in/sites/default/files/2021-12/NITI-WB_Health_Index_Report_24-12-21.pdf</Citation></Reference><Reference><Citation>Haryana I.H.D.  2021. 3rd round of sero-prevalance of anti-SARSCoV-2 IgG antibodies in Haryana, India: a population based cross sectional study.http://www.nhmharyana.gov.in/WriteReadData/userfiles/file/CoronaVirus/SSR-3%20Final%20Booklet%20with%20cover%20page_compressed.pdf</Citation></Reference><Reference><Citation>Zwane A.P., Zinman J., Van Dusen E., et al. Being surveyed can change later behavior and related parameter estimates. Proc Natl Acad Sci USA. 2011;108(5):1821&#x2013;1826. doi: 10.1073/pnas.1000776108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1000776108</ArticleId><ArticleId IdType="pmc">PMC3033258</ArticleId><ArticleId IdType="pubmed">21245314</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg D.P., Gater R., Sartorius N., et al. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med. 1997;27(1):191&#x2013;197. doi: 10.1017/s0033291796004242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0033291796004242</ArticleId><ArticleId IdType="pubmed">9122299</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel V., Araya R., Chowdhary N., et al. Detecting common mental disorders in primary care in India: a comparison of five screening questionnaires. Psychol Med. 2008;38(2):221&#x2013;228. doi: 10.1017/s0033291707002334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0033291707002334</ArticleId><ArticleId IdType="pmc">PMC4959557</ArticleId><ArticleId IdType="pubmed">18047768</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J&#xa0;Roy Stat Soc B. 1995;57(1):289&#x2013;300. doi: 10.1111/j.2517-6161.1995.tb02031.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2517-6161.1995.tb02031.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloom H.S. Minimum detectable effects: a simple way to report the statistical power of experimental designs. Eval Rev. 1995;19(5):547&#x2013;556. doi: 10.1177/0193841x9501900504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0193841x9501900504</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F., Tomasoni D., Falcinella C., et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2022;28(4):611.e9&#x2013;611.e16. doi: 10.1016/j.cmi.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelman A., Carlin J. Beyond power calculations: assessing type S (sign) and type M (magnitude) errors. Perspect Psychol Sci. 2014;9(6):641&#x2013;651. doi: 10.1177/1745691614551642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1745691614551642</ArticleId><ArticleId IdType="pubmed">26186114</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie C.E., Lowe D.J., McAuley A., et al. Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nat Commun. 2022;13(1):5663. doi: 10.1038/s41467-022-33415-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33415-5</ArticleId><ArticleId IdType="pmc">PMC9556711</ArticleId><ArticleId IdType="pubmed">36224173</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo S.M., Liu T.C., Motwani Y., et al. Factors associated with post-acute sequelae of SARS-CoV-2 (PASC) after diagnosis of symptomatic COVID-19 in the inpatient and outpatient setting in a diverse cohort. J&#xa0;Gen Intern Med. 2022;37(8):1988&#x2013;1995. doi: 10.1007/s11606-022-07523-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07523-3</ArticleId><ArticleId IdType="pmc">PMC8989256</ArticleId><ArticleId IdType="pubmed">35391623</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandeep B., Mona A., Rebecca W., et al. Long term health consequences of COVID-19 in hospitalized patients from north India: a follow up study of upto 12 months. medRxiv. 2021 doi: 10.1101/2021.06.21.21258543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.21.21258543</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L.L., Wang J., Wang Y.S., et al. 15-Month health outcomes and the related risk factors of hospitalized COVID-19 patients from onset: a cohort study. Front Med. 2022;9 doi: 10.3389/fmed.2022.854788.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.854788</ArticleId><ArticleId IdType="pmc">PMC9131089</ArticleId><ArticleId IdType="pubmed">35646985</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Li X., Gu X., et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022;10(9):863&#x2013;876. doi: 10.1016/s2213-2600(22)00126-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-2600(22)00126-6</ArticleId><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Nittas V., Gao M., West E.A., et al. Long COVID through a public health lens: an umbrella review. Public Health Rev. 2022;43 doi: 10.3389/phrs.2022.1604501.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/phrs.2022.1604501</ArticleId><ArticleId IdType="pmc">PMC8963488</ArticleId><ArticleId IdType="pubmed">35359614</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>